References: Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol. 2010 Dec;11(12):1093-101.
Goriely S., Neurath MF., and Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol. 2008 Jan;8(1):81-6
Collison L and Vignali D. Interleukin-35: Odd one out or part of the family? Immunol Rev. 2008 Dec; 226: 248-62.
Yoshimura A, Yoshida H, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura T, Takeda A, Hamano S. Two sided roles of IL-27: induction of Th1 differentiation on Naïve CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol. 2006; 177: 5377-85.
Devergne O, Coulomb-L'Herminé A, Capel F, Moussa M, Capron F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol. 2001 Nov;159(5):1763-76.